RH
Ramanjaneya Hanumanthappa Katta
About Ramanjaneya Hanumanthappa Katta
Data last updated:
Ramanjaneya Hanumanthappa Katta is a Managing Director at Smo Clinical Research (India) Private Limited (since 2007), Managing Director at Indya Clinical Research Private Limited (since 2007) and Designated Partner at Rkr Infratech Llp (since 2024). The companies operate in Pharma, Healthcare and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹56.9 Lakh; the largest is Smo Clinical Research (India) Private Limited at ₹30.4 Lakh (FY 2025). Earlier, Ramanjaneya Hanumanthappa Katta was a Director at Clintrac International Private Limited (2004–2018) and Director at Equitorial Investments Private Limited (2016–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Smo Clinical Research (India) Private Limited U73100KA2007PTC042650 | Managing Director | 30 Apr 2007 | 2007 | ₹30.4 Lakh (FY 2025) | Active |
| Indya Clinical Research Private Limited U85110KA2007PTC042648 | Managing Director | 30 Apr 2007 | 2007 | ₹26.5 Lakh (FY 2025) | Active |
| Rkr Infratech Llp ACF-2660 | Designated Partner | 02 Feb 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Clintrac International Private Limited U73100KA2003PTC032309 | Director | 25 Oct 2004 | 2003 | Active | |
| Equitorial Investments Private Limited U01403KA1995PTC018090 | Director | 23 Sep 2016 | 1995 | ₹4 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramanjaneya Hanumanthappa Katta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jakkampudi Naga Sravani | 03137538 | Smo Clinical Research (India) Private Limited , Indya Clinical Research Private Limited | Director |
| Rakshith Katta Ramanjaneya | 10324486 | Smo Clinical Research (India) Private Limited , Indya Clinical Research Private Limited and 1 more | Director |
| Rahul Katta Ramanjaneya | 10490141 | Rkr Infratech Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramanjaneya Hanumanthappa Katta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramanjaneya Hanumanthappa Katta
Ramanjaneya Hanumanthappa Katta currently holds 3 directorships: Smo Clinical Research (India) Private Limited (Managing Director, since 30 Apr 2007, revenue ₹30.4 Lakh (FY 2025)); Indya Clinical Research Private Limited (Managing Director, since 30 Apr 2007, revenue ₹26.5 Lakh (FY 2025)); Rkr Infratech Llp (Designated Partner, since 02 Feb 2024).
Ramanjaneya Hanumanthappa Katta was first appointed on 25 Oct 2004 as Director at Clintrac International Private Limited. The most recent appointment on record is 02 Feb 2024 at Rkr Infratech Llp.
The 2 current companies of Ramanjaneya Hanumanthappa Katta that report revenue have a combined latest revenue of ₹56.9 Lakh: Smo Clinical Research (India) Private Limited ₹30.4 Lakh (FY 2025); Indya Clinical Research Private Limited ₹26.5 Lakh (FY 2025).
Ramanjaneya Hanumanthappa Katta held 2 earlier board appointments: Clintrac International Private Limited (Director, 25 Oct 2004 to 23 Jul 2018); Equitorial Investments Private Limited (Director, 23 Sep 2016 to 16 Jan 2021).
The current boards of Ramanjaneya Hanumanthappa Katta's companies include Jakkampudi Naga Sravani (Smo Clinical Research (India) Private Limited), Rakshith Katta Ramanjaneya (Smo Clinical Research (India) Private Limited), Rahul Katta Ramanjaneya (Rkr Infratech Llp).